Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02140840
Title A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Arkansas
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
*Shaded cells indicate that there was no data available from for the field